Companies: 10,795·Total market cap: $144.5T
Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc.

ENSCNASDAQHealthcare● Active
$0.25
$-0.01(-3.54%)
Market Cap$2273994
P/E Ratio
52W High$2.75
52W Low$0.23
Overview

Ensysce Biosciences, Inc. (ENSC) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ENSC · as of Mar 30, 2026

Latest filing snapshot

91
+84+1200.00%vs prior year

Ensysce Biosciences, Inc. (ENSC) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
91
Change (1Y)
+84
Growth % (1Y)
+1200.00%
Revenue / Employee
$55.7K
Net Income / Employee
$-111.8K
Market Cap
$2M

ENSC Employee Count

2017 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-3091+84+1200.00%
2025-03-107+0+0.00%
2024-03-157+0+0.00%
2023-03-307+1+16.67%
2022-03-316+2+50.00%
2021-03-154+0+0.00%
2020-03-104+0+0.00%
2019-03-114+0+0.00%
2018-03-094

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Ensysce Biosciences, Inc.
ENSC
Ensysce Biosciences, Inc.YOU
91
#2
KALA BIO, Inc.
KALA
KALA BIO, Inc.
38
#3
AIM ImmunoTech Inc.
AIM
AIM ImmunoTech Inc.
21
#4
Kazia Therapeutics Limited
KZIA
Kazia Therapeutics Limited
9
#5
Can-Fite BioPharma Ltd.
CANF
Can-Fite BioPharma Ltd.
5
#6
Qualigen Therapeutics, Inc.
QLGN
Qualigen Therapeutics, Inc.
4
#7
Oragenics, Inc.
OGEN
Oragenics, Inc.
3
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ENSC peer comparison

About ENSC employees

ENSC Employees · Headcount

Ensysce Biosciences, Inc. (ENSC) employee data is sourced from the annual SEC 10-K filing. As of 2025, Ensysce Biosciences, Inc. had 91 full-time employees globally. Full-time employees only. Global consolidated headcount.

Ensysce Biosciences, Inc. employs 91 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $55,677, reflecting the company's operational efficiency.

Ensysce Biosciences, Inc.'s workforce increased by 84 (1200.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Ensysce Biosciences, Inc.'s revenue per employee of $55,677 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

ENSC Employees · 5 questions

As of the latest SEC 10-K filing (2025), Ensysce Biosciences, Inc. had 91 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Ensysce Biosciences, Inc. employee counthow many employees does Ensysce Biosciences, Inc. haveENSC total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-30